Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria
- PMID: 23196830
- PMCID: PMC3548937
- DOI: 10.1097/QAI.0b013e31827ce536
Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria
Abstract
The effect of hepatitis C virus (HCV) on antiretroviral therapy (ART) response in patients in sub-Saharan Africa is unknown. We studied 1431 HIV-infected ART initiators in Jos, Nigeria, of whom 6% were HCV coinfected. A similar proportion of HIV/HCV-coinfected and HIV-monoinfected patients achieved HIV RNA <400 copies per milliliter after 24 and 48 weeks of ART (P > 0.05). Hepatotoxicity was uncommon (0.8% and 0.33% at 24 and 48 weeks, respectively) but was more common in the HIV/HCV-coinfected group at 24 (adjusted odds ratio = 19.3; 95% confidence interval: 4.41 to 84.4) and 48 weeks (adjusted odds ratio = 56.7; 95% confidence interval: 5.03 to 636.92). HCV did not significantly impact ART response in this Nigerian cohort.
Conflict of interest statement
References
-
- Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6–9. - PubMed
-
- Turner J, Bansi L, Gilson R, et al. UK Collaborative HIV Cohort (UK CHIC) Study. The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. J Viral Hepat. 2010;17:569–77. - PubMed
-
- Sullivan PS, Hanson DL, Teshale EH, et al. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. AIDS. 2006;20:1171–1179. - PubMed
-
- Barth RE, Huijgen Q, Taljaard J, et al. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14:1024–31. - PubMed
-
- Charles Chaselaand the BAN Study Team. Prevalence of Hepatitis C Virus Infection among Human Immunodeficiency Virus Type-1 Infected Pregnant Women in Malawi: The BAN Study. Presented at: 17th Conference on Retroviruses and Opportunistic Infections; San Francisco. February 2010; [Oral Presentation # 693]
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
